Christopher E. Pope

2.8k total citations
36 papers, 1.5k citations indexed

About

Christopher E. Pope is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Christopher E. Pope has authored 36 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 18 papers in Molecular Biology and 6 papers in Infectious Diseases. Recurrent topics in Christopher E. Pope's work include Cystic Fibrosis Research Advances (22 papers), Gut microbiota and health (14 papers) and Tracheal and airway disorders (5 papers). Christopher E. Pope is often cited by papers focused on Cystic Fibrosis Research Advances (22 papers), Gut microbiota and health (14 papers) and Tracheal and airway disorders (5 papers). Christopher E. Pope collaborates with scholars based in United States, Canada and New Zealand. Christopher E. Pope's co-authors include Lucas R. Hoffman, Samuel I. Miller, Daniel J. Wolter, Elhanan Borenstein, Jane L. Burns, Hillary S. Hayden, M. Brittnacher, Matthew C. Radey, Bonnie W. Ramsey and Nicole Mayer-Hamblett and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Christopher E. Pope

34 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher E. Pope United States 20 897 704 233 220 197 36 1.5k
Lisa A. Carmody United States 15 717 0.8× 813 1.2× 80 0.3× 117 0.5× 233 1.2× 24 1.3k
Catherine Doherty United Kingdom 18 468 0.5× 1.2k 1.7× 309 1.3× 82 0.4× 242 1.2× 26 1.7k
Shawn T. Clark Canada 13 441 0.5× 405 0.6× 210 0.9× 118 0.5× 163 0.8× 20 810
Colin Harbour Australia 16 621 0.7× 940 1.3× 319 1.4× 110 0.5× 145 0.7× 28 1.5k
Irene Bianconi Italy 19 663 0.7× 240 0.3× 228 1.0× 199 0.9× 88 0.4× 27 1.0k
Helder Pedro United Kingdom 8 1.0k 1.1× 529 0.8× 33 0.1× 168 0.8× 262 1.3× 9 2.1k
Nina Cramer Germany 19 1.1k 1.3× 637 0.9× 757 3.2× 100 0.5× 117 0.6× 30 1.6k
Kay A. Ramsay Australia 18 377 0.4× 403 0.6× 355 1.5× 74 0.3× 129 0.7× 40 825
Andrea Petrucca Italy 22 573 0.6× 101 0.1× 282 1.2× 183 0.8× 275 1.4× 47 1.5k
Floriana Santangelo Italy 13 493 0.5× 113 0.2× 77 0.3× 177 0.8× 120 0.6× 16 884

Countries citing papers authored by Christopher E. Pope

Since Specialization
Citations

This map shows the geographic impact of Christopher E. Pope's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher E. Pope with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher E. Pope more than expected).

Fields of papers citing papers by Christopher E. Pope

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher E. Pope. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher E. Pope. The network helps show where Christopher E. Pope may publish in the future.

Co-authorship network of co-authors of Christopher E. Pope

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher E. Pope. A scholar is included among the top collaborators of Christopher E. Pope based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher E. Pope. Christopher E. Pope is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duong, Jennifer, Christopher E. Pope, Hillary S. Hayden, et al.. (2024). Alterations in the fecal microbiota in patients with advanced cystic fibrosis liver disease after 6 months of elexacaftor/tezacaftor/ivacaftor. Journal of Cystic Fibrosis. 23(3). 490–498. 8 indexed citations
2.
Lee, Dale, Christopher E. Pope, Hillary S. Hayden, et al.. (2024). Reverse‐engineered exclusive enteral nutrition in pediatric Crohn's disease: A pilot trial. Journal of Pediatric Gastroenterology and Nutrition. 78(5). 1135–1142. 2 indexed citations
3.
Green, Nicole, David L. Suskind, Marshall Brown, et al.. (2024). The impact of a whole foods dietary intervention on gastrointestinal symptoms, inflammation, and fecal microbiota in pediatric patients with cystic fibrosis: A pilot study. Clinical Nutrition. 43(11). 156–163. 1 indexed citations
4.
Pope, Christopher E., Kathryn B. Whitlock, Paul Hodor, et al.. (2023). A Refined, Controlled 16S rRNA Gene Sequencing Approach Reveals Limited Detection of Cerebrospinal Fluid Microbiota in Children with Bacterial Meningitis. Microbiology Spectrum. 11(3). e0036123–e0036123. 3 indexed citations
5.
Hodor, Paul, Christopher E. Pope, Kathryn B. Whitlock, et al.. (2021). Molecular Characterization of Microbiota in Cerebrospinal Fluid From Patients With CSF Shunt Infections Using Whole Genome Amplification Followed by Shotgun Sequencing. Frontiers in Cellular and Infection Microbiology. 11. 699506–699506. 6 indexed citations
6.
Eng, Alexander, Hillary S. Hayden, Christopher E. Pope, et al.. (2021). Infants with cystic fibrosis have altered fecal functional capacities with potential clinical and metabolic consequences. BMC Microbiology. 21(1). 247–247. 12 indexed citations
7.
Meeker, Stacey, Naseer Sangwan, M. Brittnacher, et al.. (2020). CFTR dysregulation drives active selection of the gut microbiome. PLoS Pathogens. 16(1). e1008251–e1008251. 59 indexed citations
8.
Hayden, Hillary S., Alexander Eng, Christopher E. Pope, et al.. (2020). Fecal dysbiosis in infants with cystic fibrosis is associated with early linear growth failure. Nature Medicine. 26(2). 215–221. 66 indexed citations
9.
Nelson, Maria T., Christopher E. Pope, Robyn L. Marsh, et al.. (2019). Human and Extracellular DNA Depletion for Metagenomic Analysis of Complex Clinical Infection Samples Yields Optimized Viable Microbiome Profiles. Cell Reports. 26(8). 2227–2240.e5. 109 indexed citations
10.
Manor, Ohad, Roie Levy, Christopher E. Pope, et al.. (2016). Metagenomic evidence for taxonomic dysbiosis and functional imbalance in the gastrointestinal tracts of children with cystic fibrosis. Scientific Reports. 6(1). 22493–22493. 97 indexed citations
11.
Pope, Christopher E., et al.. (2015). Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome. Mammalian Genome. 26(5-6). 222–234. 26 indexed citations
12.
Mayer-Hamblett, Nicole, Margaret Rosenfeld, Ronald L. Gibson, et al.. (2014). Pseudomonas aeruginosa In Vitro Phenotypes Distinguish Cystic Fibrosis Infection Stages and Outcomes. American Journal of Respiratory and Critical Care Medicine. 190(3). 289–297. 79 indexed citations
13.
Gast, Chris, Leah Cuthbertson, Geraint B. Rogers, et al.. (2014). Three Clinically Distinct Chronic Pediatric Airway Infections Share a Common Core Microbiota. Annals of the American Thoracic Society. 11(7). 1039–1048. 68 indexed citations
14.
Brown, Perry, Christopher E. Pope, Robyn L. Marsh, et al.. (2014). Directly Sampling the Lung of a Young Child with Cystic Fibrosis Reveals Diverse Microbiota. Annals of the American Thoracic Society. 11(7). 1049–1055. 54 indexed citations
15.
Simon, Tamara D., Christopher E. Pope, Samuel R. Browd, et al.. (2014). Evaluation of Microbial Bacterial and Fungal Diversity in Cerebrospinal Fluid Shunt Infection. PLoS ONE. 9(1). e83229–e83229. 21 indexed citations
16.
Mayer-Hamblett, Nicole, Bonnie W. Ramsey, Hemantha D. Kulasekara, et al.. (2014). Pseudomonas aeruginosa Phenotypes Associated With Eradication Failure in Children With Cystic Fibrosis. Clinical Infectious Diseases. 59(5). 624–631. 55 indexed citations
17.
Wolter, Daniel J., Julia Emerson, Sharon McNamara, et al.. (2013). Staphylococcus aureus Small-Colony Variants Are Independently Associated With Worse Lung Disease in Children With Cystic Fibrosis. Clinical Infectious Diseases. 57(3). 384–391. 134 indexed citations
18.
Pope, Christopher E., et al.. (2010). Species distribution of Burkholderia cepacia complex isolates in cystic fibrosis and non-cystic fibrosis patients in New Zealand. Journal of Cystic Fibrosis. 9(6). 442–446. 24 indexed citations
19.
McTavish, Sharla, Christopher E. Pope, Carolyn Nicol, et al.. (2009). Multilocus sequence typing ofCampylobacter jejuni, and the correlation between clonal complex and pulsed-field gel electrophoresis macrorestriction profile. FEMS Microbiology Letters. 298(2). 149–156. 15 indexed citations
20.
Heffernan, Helen, et al.. (2009). Prevalence and types of extended-spectrum β-lactamases among urinary Escherichia coli and Klebsiella spp. in New Zealand. International Journal of Antimicrobial Agents. 34(6). 544–549. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026